Tuberculosis Current Events | Tuberculosis News | 9
|
| Page
9 of
10 |
198 Results |
|
|
|
Sort By:
Page Views | Date |
Misuse of common antibiotic is creating resistant TB
Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used to fight a number of different infections such as sinusitis and pneumonia. view more (2009-08-11)
Tropical disease experts call for a 'Global Fund to Fight Neglected Tropical Diseases'
An international team of tropical disease control experts has urged the global health and development community, and particularly the G8 leaders, to establish a new financing mechanism to combat the neglected tropical diseases (NTDs) of poverty. view more (2008-03-26)
Persistent bacterial infection exploits killing machinery of immune cells
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections. view more (2008-11-03)
TNF-Alpha Blocker Infliximab Highly Effective For Patients With Ankylosing Spondylitis
BERLIN, Germany - 6 April 2002 -- For the first time, there is a therapy that can significantly reduce disease activity for the majority of patients with ankylosing spondylitis (AS), a chronic inflammatory rheumatic disease that often leads to stiffening and subsequent fusion of the spine. The study, published in the April 6 issue of "The... view more... (2002-04-05)
NORTH KOREA'S PUBLIC-HEALTH TRAGEDY (p 628)
Former Reuters journalist John Owen-Davies describes the recent decay in North Korea's health-care system in this week's issue of THE LANCET. He comments how the country's economic decline after the break-up of the Soviet Union, and the devastation caused by flooding in 1995, has transformed the health-care system of a nation that was once the... view more... (2001-02-21)
New directions for cardiovascular medicine (p 754)
Issue 6 September 2003 Embargoed 0001 h (London time) 5 September 2003. Heart disease is the number one cause of death in developed countries (over 700 000 deaths annually in the USA, 256 per 100 000 population). Worldwide, heart disease kills 15 million people a year and more than half of these deaths occur in the developing world. Today's... view more... (2003-09-03)
Combating AIDS, malaria and tuberculosis: Commissioner Busquin in Dakar for clinical trials partnership launch
European Research Commissioner Philippe Busquin will visit Senegal from 22 to 24 February to launch the operational phase of the EUR600 million "European and Developing Countries Clinical Trials Partnership" programme. The visit also aims at encouraging West African countries to mobilise around this important initiative. The European... view more... (2004-02-23)
Why is long-term therapy required to cure tuberculosis?
Understanding why other bacteria become resistant to antibiotics could hold the key to understanding why TB takes so long to cure, say researchers in a policy paper in PLoS Medicine. view more (2007-03-20)
'New' science gleans knowledge from ancient lands and societies
Understanding how pollution effects the dynamics of Earth and the spread of disease in ancient times are two areas in which ASU's new School of Human Evolution & Social Change can make a dramatic and immediate impact. view more (2005-11-08)
NIAID researchers show how promising tuberculosis (TB) drug works
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). view more (2005-12-27)
Countries Need Greater Support And Less Stringent Conditions If Global Fund Goals Are To Be Met
The London School of Hygiene & Tropical Medicine (LSHTM) will today publish interim findings relating to how the Global Fund to Fight AIDS, Tuberculosis and Malaria is being implemented in four African countries. The Fund was established in 2002 as a mechanism to get additional resources to affected countries to control these devastating... view more... (2004-06-30)
American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
The American Thoracic Society (ATS) has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis (TB) medications. view more (2006-11-08)
MIT project uses personal digital assistants to track TB data
For patients who have drug-resistant forms of tuberculosis, it's critical to monitor the disease as closely as possible. That means monthly testing throughout a two-year course of powerful antibiotics, with injections six days a week for the first six months. view more (2009-02-12)
European Commissioner Busquin Presents Clinical Trials Programme To African Health Ministers
At the WHO conference in Johannesburg on 1 September, European Research Commissioner Philippe Busquin will present the Europe-Developing Countries Clinical Trials Partnership (EDCTP) to the Ministers for Health of 46 African States. EDCTP aims to combat HIV/AIDS, malaria and tuberculosis with a EUR600 million budget to which the European Union has... view more... (2003-09-01)
Study helps identify which populations of foreign-born persons living in US at higher risk of TB
The relative yield of finding and treating latent tuberculosis is particularly high among higher-risk groups of foreign-born persons living in the U.S., such as individuals from most countries of sub-Saharan Africa and Southeast Asia. view more (2008-07-23)
XDR-TB: Deadlier and more mysterious than ever
New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials. view more (2008-11-06)
Gains in access to antiretroviral treatment come with some costs
In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. view more (2009-04-28)
Smear campaign: Faster detection of multidrug-resistant TB for public health
There is a new tool in the arsenal to fight multidrug-resistant tuberculosis (MDR-TB): a rapid diagnostic test that can function in high-burden settings such as public health clinics. view more (2008-04-01)
Antibody-based therapies effective at controlling malaria
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S. McIntosh from the University of Nottingham in a paper published this week in the open-access journal PLoS Pathogens. view more (2007-05-18)
Europe mobilises full research potential to combat poverty-related diseases EDCTP launch conference, Barcelona, 19-20 April 2002
On 19-20 April, 2002, a conference, co-organised by the European Commission (DG Research) and the Spanish Presidency, will launch the first phase of the European-Developing Countries Clinical Trials Programme (EDCTP) - a new programme to accelerate the clinical development of drugs and vaccines against poverty-related diseases: AIDS, malaria and... view more... (2002-04-16)
|
|
| Page
9 of
10 |
198 Results |
|
|
|
Sort By:
Page Views | Date |
|
